chrisvoncsefalvay/vaers-outcomes huggingface dataset:
So on Sunday  9/11/2022 I started feeling run down and had drainage to the back of my throat and Monday I had felt run down, tightness in my throat and tested with a COVID-19 home test kit provided by the government and tested negative just went thru the whole day feeling yuck didn't sleep much with runny nose on Tuesday.  I did another COVID-19 home test and it came back positive.  On Wednesday I woke up feeling a little better the nasal stuff was shutting down and I had really bad vertigo and unless I didn't move at all, I was dizzy and nauseated and I went out ad got some Dramamine and that helped a lot with the vertigo and on Thursday I still had dizziness but less nausea and my wife encouraged me to speak with my physician and on Friday I still had mucus but never got into my lungs had a tele health visit and he recommended Dramamine for the vertigo and on Sunday I stopped taking it but had small interments bouts of nausea.
Moderate injection site, pain, swelling, erythema, and heat/hot to touch. Body ache, chills, joint soreness. Reaction to Tdap vaccine.
pt recv vax 26JUL95 & MAY97 pt devel breakthrough chickenpox consisting of greater than 300 lesions including oral, genital & eye details;
Patient presented to the clinic diaphoretic with slurred speech, altered mental status and significant weakness unable to walk or bear weight.  He was sent out 911 for hospital evaluation.  He was admitted and was in the hospital for 48 hours.  Acute CVA was ruled out.  Within 48 hours after presentation of symptoms he was back to baseline.
1 day p/vax pt devel lt sided facial numbness; 3 days post vax seen in ER where serology for HIV & lyme disease was performed (results unk to reporter);ER MD dx bell's palsy;
No adverse event.  patient received second dose pfizer instead of Moderna. Patient has received the first   Moderna, because exceptional second dose was given Pfizer.
A couple of minutes, post vax, she came back to Employee Health and said it felt like her throat was swelling. She was taken to ER and given IV with epinephrine Medrol dose-pack; Pepcid; Benadryl and Cortisone. A follow up report received 10/11/2001 adds: Taken to the ER of hospital for evaluation of rapid onset of swelling of the throat after immunization for influenza and 2nd shot in series of Hep B immunization. ER chart states Dx as acute angiodema 2ndary to Hep B vaccine.
no side effects; Improperly stored vaccine was administered; This spontaneous report was received from a nurse referring to a patient of unknown age and gender.  The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On 16-AUG-2023, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA) (PROQUAD) injection, administered for prophylaxis (lot# W012730, expiration date: 16-OCT-2023; strength and route of administration were not provided). The vaccine was improperly stored at 6 degrees Celsius for 7 hours. There was no previous temperature excursion (product storage error). No side effects were reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2309USA008121: US-009507513-2309USA008458: US-009507513-2309USA008482: US-009507513-2309USA008212:
Drug dose administration interval too long; Soreness at injection site; Shoulder soreness; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 51-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of musculoskeletal pain (received 1st dose in March 2019, refer case US2020032232).   On 19th February 2020, the patient received the 2nd dose of Shingrix. In February 2020, less than a week after receiving Shingrix, the patient experienced injection site pain and shoulder soreness. On 19th February 2020, the patient experienced drug dose administration interval too long. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the injection site pain and shoulder soreness were recovering/resolving and the outcome of the drug dose administration interval too long was unknown.   It was unknown if the reporter considered the injection site pain and shoulder soreness to be related to Shingrix.  Additional case details were reported as follows: The patient received the 2nd dose and experienced soreness at the injection site and soreness in her right shoulder. On 19th February 2020, the patient received the 2nd dose of Shingrix, which led to lengthening of vaccination schedule. The patient was prescribed methotrexate and she wants to know if she can take it Informed patient that immunosuppressive therapies may reduce the effectiveness of Shingrix, referred patient to her healthcare professional. The patient consented to follow up.
Speech impaired, trouble focusing, tongue swollen, tingle in tongue, and numbness in tongue, yellow film on tongue in the morning. Blurred eyes, trouble tasting food, and intermittent unsteadiness.
PT ACTUALLY GOT THE BIVALENT PFIZER BOOSTER BUT IT WOULDN'T LET ME PICK THAT ONE. PT CAME TO THE PHARMACY TODAY 6/8/23 TO SHOW ME HIS LEFT ARM. HE SAID HE RECIEVED THE PFIZER BIVALENT BOOSTER ON 6/2/23 AND THEN HIS ARM TURNED REALLY RED WITH A RASH DOWN BELOW THE INJECTION SITE AND NOW IS TURNING PURPLE AND YELLOW. THIS WEIRD RASH STARTS LIKE 2 OR 3 INCHES BELOW THE INJECTION SITE AND CONTINUES TO ALMOST THE ELBOW.  PT SAID IT DOESN'T HURT AND IT IS NOT WARM TO THE TOUCH AND HE HAS NO OTHER SYMPTOMS
Approximately 25 minutes post vaccine, attendee began to complain of dizziness, clammy, nausea and arm numbness.  Patient's vitals were taken. 50Mg of Benadryl was given.  The attendee was monitored for 45 minutes and released from site. He was accompanied by his older sister. No loss of consciousness was observed. The attendee remained alert and oriented the entire time.
Lip swelling; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (Lip swelling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In October 2021, the patient experienced LIP SWELLING (Lip swelling). At the time of the report, LIP SWELLING (Lip swelling) outcome was unknown.            Patient  does have lip fillers but she does have some lip swelling. No concomitant product was provided by the reporter. No treatment medication was provided.
pt recvd vax & w/in 2hrs post vax exp a urticarial rash;pt was treated w/DPH inj & DPH;sx persist
You only allowed me to put in one set of dates, but I had my two shots April 7th and April 28.  Exactly 3 days later (Saturday morning) at exactly the same time, I had a migraine aura -- something I have had before, but not for a long time.
318 patients received dose from vials beyond 30-day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Oct-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date). On 07-Oct-2021, EXPIRED PRODUCT ADMINISTERED (318 patients received dose from vials beyond 30-day use by date) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Date of Refrigeration was 19-Aug-2021.  No Concomitant and Treatment medication were reported.
Petechial rash on infant back and upper arms. Mother stated baby woke up with swollen eyes but resolve by the time baby showed up in the clinic @ 12 noon. Mother stated no changes in babys formula, soap. advise to go pmd if condition worses.
This spontaneous report was received from a pharmacist refers to a female patient of unknown age. On an unknown date the patient was vaccinated with HepB vaccine (manufacturer unknown) (dose, lot # and route of administration was not reported). On an unknown date the patient experienced an unspecified reaction to the unspecified preservative in HepB vaccine (manufacturer unknown). It was reported that RECOMBIVAX could not be ruled out. The outcome of the event was reported as recovered/resolved on unknown date. Additional information has been requested.
Dermatographia Rashes appear where skin has friction contact. Itchy welted marks appear for about 30 minutes and then disappear. Will reappear again on other places all over the body. Usually heat triggers and rough clothing and scratching.
Serum sickness reaction with local reaction, arthralgia, pain, fatigue in multiple joints.
heart issue; This is a spontaneous report from a non-contactable consumer (patient). A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration on an unspecified date as unknown, single for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient had a significant reaction and went to emergency room with a heart issue. The outcome of the heart issue was unknown.  No follow-up attempts are possible; information about batch/ lot number cannot be obtained.
Patient had instant pain down left arm. Had increased swelling and redness from shoulder down to the elbow.  Severe pain that tylenol didn't even help. Did take tylenol and benadryl to help with pain. helped a little but redness returned and so did pain.
Information has been received from a physician concerning a 84 year old female patient with chronic asthma and chronic obstructive pulmonary disease and a history of hospitalization 3 times this year for pneumonia and several issues who on an unspecified date "about a week ago", was vaccinated SC with a second dose of PNEUMOVAX.  Concomitant therapy included ADVAIR.  On an unspecified date, the patient developed a cough once or twice a day since the vaccination.  It was reported that it was noticed more by the patient's husband then by herself.  It was also reported that the patient refuses to regularly use her inhaled steroids.  Laboratory diagnostic studies included Spirometry readings from 19-SEP-2007 which resulted in mild restriction, 14-MAY-2007 which also resulted in mild restriction and 20-AUG-2007 which resulted in borderline obstruction.  At the time of this report, the patient's outcome was unknown.  No product quality complaint was involved.  Additional information has been requested.
Information has been received from a physician and nurse concerning a 71 year old male with prostate cancer and no drug allergy who in 2002 was vaccinated with the first dose of PNEUMOVAX 23. On 29-JUL-2009, the patient received the second dose of PNEUMOVAX 23. Concomitant therapy included AGGRENOX, NORVASC, metformin, TOPROL XL TABLETS, simvastatin, CASODEX, HYTRIN and hydrochlorothiazide. Subsequently the patient developed cellulitis at the injection site. The patient had visited the office and was being treated with KEFLEX. At the time of the report, the patient had not recovered. Additional information has been requested.
Muscle spasms/twitches that started roughly 6 hours after administration and peaked around 12 hours; Feet, calf, thighs, abdomen, bag, shoulder, neck and roof of mouth were all twitching; This is a spontaneous report from a contactable other healthcare professional (patient). A 20-year-old female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- unknown) via intramuscularly in left arm on 18Feb2021 at 12:00 as dose 2 single (at the age of 20-year-old) for COVID-19 immunization. Medical history was reported as none. Patient had no Known allergies. Patient did not receive any other vaccine in four weeks. Concomitant medication in two weeks included ethinylestradiol, norgestimate (TRI LINYAH). Patient was not pregnant at the time of vaccination. Historical vaccine included BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- unknown) via intramuscularly in left arm on 23Jan2021 at 10:00 AM as dose 1 single (at the age of 20-year-old) for COVID-19 immunization The patient was not diagnosed with Covid prior to vaccination. On 18Feb2021 at 18:00, patient experienced muscle spasms/twitches that started roughly 6 hours after administration and peaked around 12 hours. Feet, calf, thighs, abdomen, bag, shoulder, neck and roof of mouth were all twitching. No treatment was received for the adverse events. Patient had not Covid tested post vaccination. The outcome of the events was recovering.  Information on the lot/batch number has been requested.  Follow-up attempts completed. No further information expected.
10/04/04: rash right chest, right arm , left arm, right lateral lower side, calf, 25-34 in number. 10/05/2004: family reports 54 in number
I feel one day dizzy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious), outcome "recovered", described as "I feel one day dizzy".  Additional information: The patient received both vaccinations last year. The patient had the first vaccination with Pfizer it was like after one, not even one week the patient felt one day dizzy but it goes away and that's it.  The lot number for bnt162b2 was not provided and will be requested during follow up. Sender's Comments: Linked Report(s) : US-PFIZER INC-202200410067 same patient and drug, different event separated in time
generalized body aches the following morning; Injection site pain within a few hours; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 49-year-old male patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 18Sep2023 at 16:30 as dose 5 (booster), single (Batch/Lot number: unknown) at the age of 49 years, in right arm for covid-19 immunisation; influenza vaccine inact split 3v (FLUARIX), on 18Sep2023 as dose 1, single (Batch/Lot number: unknown), in left arm. The patient had no relevant medical history. Concomitant medication(s) included: MAGNESIUM CITRATE; CO-Q10-CHLORELLA; MULTIVITAMIN [VITAMINS NOS]; FISH OIL. Vaccination history included: Covid-19 vaccine (Dose: 1-4, Manufacturer: Unknown), for COVID-19 Immunization. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 18Sep2023 at 20:00, outcome "recovering", described as "Injection site pain within a few hours"; PAIN (non-serious) with onset 19Sep2023, outcome "recovering", described as "generalized body aches the following morning". Therapeutic measures were not taken as a result of vaccination site pain, pain.  The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Information has been received from a Dr. of pharmacy concerning a female pt with sulfa and mercury allergies who's current medications include dilitiazem hydrochloride (manufact. unknown) who was vaccinated with her "last dose" of pneumococcal vaccine 23 polyvalent, "sometime ago." Subsequently the pt experienced injection site swelling and redness in the left arm. Medical attention was not sought. Additional information has been requested.
On my first dose vaccine, 01-22-2021, I went to bed at 9:00pm.  On 01-23-2021 in the next morning I woke up with heart racing with chest pressure, felt dizzy with SOB. I called an ambulance and they performed an EKG which was normal. I went to the hospital and they did triponine values, EKG and I was released after 24 hours of monitoring. About five days later I went to see my PCP for a physical I had scheduled. He performed another EKG and this time it looked abnormal, showed I had gone into cardiac arrest and other tests, such as stress test, reactive blockages test and heart test were also performed.  I had no blockage nor heart attack. I then drove home and since then I have been going to doctor's appointments. I have also scheduled a second dose of Moderna vaccine in three to four weeks.
This spontaneous case reported by a consumer, describes the occurrence of influenza-like illness (flu-like symptoms), asthenia (in bed for one whole day) and fatigue (extreme tiredness for about 3-4 days) in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 038K20A) for COVID-19 immunization. No medical history reported. On Mar 25, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced influenza-like illness (flu-like symptoms), asthenia (in bed for one whole day) and fatigue (extreme tiredness for about 3-4 days). At the time of the report, influenza-like illness (flu-like symptoms), asthenia (in bed for one whole day) and fatigue (extreme tiredness for about 3-4 days) outcome: unknown/not provided The reporter did not provide any causality assessments. Treatment: Tylenol- didn't help. Concomitant product details not provided. This case linked to MOD-2021-039893 (patient link).
Dizziness when laying down Dizziness when getting up after lying down Dizziness when moving quickly Brain feels "strange", not normal feeling
Patient had received second Pfizer vaccination after no reported issues with the first dose.  Patient was observed post vaccination without incident and released.  Patient developed wheezing and attempted to treat with her albuterol inhaler but did not improve.  patient presented to the ED approximately 2 hours after vaccination and was admitted for respiratory failure and placed on BiPAP for a brief period of time.  patient has known history of Asthma Exacerbation requiring hospitalization and intubations.  D/C diagnosis Asthma Exacerbation
This spontaneous report was received from an office administrator and refers to an unspecified amount of patients (age and gender unknown).   The reporter stated that on unknown dates in 2016, the patients received improperly stored doses of ROTATEQ orally (lot # M017514, expiration date: 07-NOV-2017, dose not provided). No adverse effects were reported. Temperature excursion occurred on 01-SEP-2016: Temperature: 45F Time frame: 18 hours Digital data logger was involved. This is one of several reports received from the same source. Additional information has been requested.; Sender's Comments:  US-009507513-1610USA011550:
Chronic cough during the night-needed breathing treatment, painful urination, 101° temp, entire body aching, bones aching.
Wide awake all night long. Pulse seemed normal and body was tired but mind was busy and awake all night. Also sore around injection site but nothing unusual.
She feels she has a cold in her chest; cold; influenza A; Hacking cough; voice affected; chest burning; Difficulty breathing; chest congestion; This is a spontaneous report from a contactable consumer. This 74-year-old female consumer reported that she started to receive the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number EL9266) via an unspecified route of administration in arm left on 03Mar2021 08:45AM (at the age of 74-year-old) at single dose for COVID-19 immunisation. First dose of BNT162b2 (Lot number GM or EM9809) was taken on 10Feb2021 (at the age of 74-year-old) in left arm (way up high on the shoulder) for COVID-19 immunisation. Relevant medical history included bronchitis, chronic obstructive pulmonary disease (due to environmental toxins), allergy to different dyes (allergic to yellow, purple, and blue dye) and allergy to medications. The patient has never been a drinker or smoker. Concomitant medications were not reported. A week or so after the second dose, she thought she was having a cold. It has affected her voice and breathing. She thought she had bronchitis.  She was going to her doctor on 04May2021. She had a hacking cough and she doesn't know what she has if it isn't a cold. She wondered if it was connected to the vaccine or is it bronchitis. The more she talks the more difficulty in her chest. She was prescribed Robitussin DM cough syrup by her doctor and was taking honey lemon cough drops. She also had congestion in her chest ever since. She has been having like a cold in her chest. It was heard how she was sounding. She never thought it was connected to the vaccine and never expected this to last for this long. The patient asked whether it could be a residual side effects of the vaccine and questioned if this could have had any effect on the COPD. She stated she was not having any problems with it and she has had it for years. Her cough has been the same, she takes a dose of DM cough syrup or a cough drop during the day. Robitussin was working. She was drinking lots of fluids, between 74-96 ounces of water per day. The doctor told her she had A influenza, but she thought she had COVID because she had all the symptoms, but they said A influenza and treated her for influenza A. That morning she had difficulty breathing like bronchitis, her chest was burning inside and was always like that, her talking aggravates everything and she had deep breathing. Her physician said her chest was clear after she thought she had bronchitis at her previous visit. She does not have any questions, she was calling to report an event, she is calling her doctor for further guidance. Cough, difficulty breathing, voice changed required a visit at physician office. Onset date for hacking cough, voice affected, chest burning, difficulty breathing and chest congestion was 10mar2021, while onset date for the other events was unknown. Hacking cough, voice affected, chest burning, difficulty breathing and chest congestion were not resolved, outcome of the other events was unknown.
Approximately 15-20  minutes post vaccination patient began to feel "tingly" in his right arm extending from injection site to hand and all the the way up to his cheek.  Moments later he began to have the same tingly feeling bilaterally in his feet.  Shortly thereafter he also had some slight nausea/unsettled stomach feeling and also complained of dry mouth.  Patient remained on-site for an additional 30 minutes before leaving the site.
devel fever, muscle aches/pains in lower extremities w/in 48hr of vax;
Within 1 hour MILD light headiness, passing headache, chills, sweating,  Within 3 hours LEFT EAR HEARING LOSS about 25% to 50% have not yet resolved & ENT office recommends PCP prescribe prednisone rapid taper pack  ASAP